Presence of antiphospholipid antibodies in COVID-19: a case series study

Annals of the Rheumatic Diseases - Tập 80 Số 5 - Trang e73-e73 - 2021
Luis M. Amezcua‐Guerra1, Gustavo Rojas‐Velasco2, Malinalli Brianza-Padilla3, Armando Vázquez-Rangel2, Ricardo Márquez-Velasco3, Francisco M. Baranda-Tovar2, Rashidi Springall3, Héctor González‐Pacheco2, Yaneli Juárez-Vicuña3, Claudia Tavera-Alonso2, Fausto Sánchez‐Muñoz3, Marisol Hernández-Salas2
1Departamento de Inmunología, Instituto Nacional de Cardiologia Ignacio Chavez, 14080 Tlalpan, Mexico
2Intensive Care Unit, Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City, Mexico
3Immunology, Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City, Mexico

Tóm tắt

Từ khóa


Tài liệu tham khảo

10.1136/annrheumdis-2020-217566

American Society of Hematology . COVID-19 and aPL antibodies: frequently asked questions, 2020. Available: https://www.hematology.org/covid-19/covid-19-and-apl-ab [Accessed 23 May 2020].

Harzallah I , Debliquis A , Drénou B . Lupus anticoagulant is frequent in patients with Covid‐19. J Thromb Haemost 2020.doi:10.1111/jth.14867

Helms, 2020, High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study, Intensive Care Med, 10.1007/s00134-020-06062-x

10.1007/s11926-018-0773-x

Thông tin
Thông tin xuất bản

Annals of the Rheumatic Diseases

Tập 80 Số 5

e73-e73

Thông tin tác giả